Long Read Sequencing Market
Long Read Sequencing Market Forecasts to 2032 - Global Analysis By Product (Instruments, Consumables and Services), Technology (Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing, Synthetic Long-Read Sequencing and Other Technologies), Application, End User and By Geography
|
Years Covered |
2024-2032 |
|
Estimated Year Value (2025) |
US $1.32 BN |
|
Projected Year Value (2032) |
US $5.87 BN |
|
CAGR (2025-2032) |
23.7% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Long Read Sequencing Market is accounted for $1.32 billion in 2025 and is expected to reach $5.87 billion by 2032 growing at a CAGR of 23.7% during the forecast period. The technique known as ""long read sequencing"" creates lengthy, continuous reads of DNA strands, usually ranging in length from thousands to millions of base pairs. It enables more precise mapping of intricate genomic areas, including structural variations, repetitive sequences, and full-length transcripts, in contrast to conventional short-read techniques. Real-time sequencing and minimal sample preparation are made possible by technologies such as Oxford Nanopore's platforms and Pacific Biosciences' SMRT. Long read sequencing is a potent tool in genomics research because it improves genome assembly, clinical diagnostics, and evolutionary studies by giving genetic information more context and continuity.
Market Dynamics:
Driver:
Increasing demand for accurate genome assembly
Complex genomic areas are challenging to resolve with short reads, but long read sequencing methods make this possible. They provide more precision in detecting big insertions or deletions, repetitive sequences, and structural alterations. Applications in personalised treatment, disease research, and evolutionary studies all depend on this accuracy. Long read platforms are becoming more and more popular as academics and medical professionals place a higher value on accurate and comprehensive genetic data. In order to satisfy this rising demand, industry participants are investing in sophisticated sequencing systems.
Restraint:
High cost and error rates
The sophisticated technology required necessitates costly equipment and chemicals, which limits small labs' access to it. Its use in extensive clinical and scientific settings is restricted by the high expense of sequencing each sample. Furthermore, the correctness and dependability of data are jeopardised by the error rates in long-read outputs. This frequently calls for additional short-read sequencing for validation, which raises the expense and time. As a result, users hesitate to fully transition to long-read platforms, slowing market expansion.
Opportunity:
Growing use in clinical diagnostics and personalized medicine
Gene fusions, complicated genomic areas, and structural changes that short reads frequently overlook can be accurately detected by long read sequencing. For the diagnosis of complex diseases and rare genetic abnormalities, this accuracy is essential. This helps personalised medicine by customising care according to each patient's distinct genetic composition. Additionally, the technology helps cancer genomics and non-invasive prenatal diagnostics. Long read sequencing is gaining traction as the need for accurate, customised healthcare increases.
Threat:
Competition from short read technologies and emerging sequencing platforms
Adoption is facilitated by the established, widely used infrastructure and user familiarity of short read methods. Because of its precision and high throughput, short reads are still used in many clinical and research applications. New platforms are bridging the read-length divide without sacrificing price. Long read suppliers are under pressure to innovate and cut prices quickly as a result. Market expansion is therefore confronted with slower adoption and more intense pricing competition.
Covid-19 Impact
The COVID-19 pandemic positively impacted the Long Read Sequencing market by accelerating genomic research and diagnostic development. Increased demand for accurate and rapid pathogen detection drove investments in sequencing technologies. Long read sequencing played a vital role in studying virus mutations, improving surveillance, and supporting vaccine development. Additionally, collaborative efforts between governments and biotech firms expanded sequencing capacity globally. Despite initial supply chain disruptions, the market experienced significant growth due to heightened awareness of genomic tools in healthcare preparedness and response.
The consumables segment is expected to be the largest during the forecast period
The consumables segment is expected to account for the largest market share during the forecast period, due to ensured recurring demand through each sequencing run. These include reagents, kits, and flow cells, which are essential for accurate and efficient long-read data generation. Technological advancements in consumables enhance read length, accuracy, and throughput, attracting more research and clinical applications. As the adoption of long-read sequencing grows in fields like genomics and oncology, the need for high-performance consumables rises. This steady and expanding demand strengthens the overall market growth and profitability.
The hospitals & healthcare providers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals & healthcare providers segment is predicted to witness the highest growth rate, due to the growing demand for accurate and comprehensive genomic data for patient diagnostics and personalized treatment. These institutions increasingly adopt long read sequencing to identify complex genetic variations that short read methods may miss. Rising incidences of rare genetic disorders and cancer further drive the need for precise genomic analysis in clinical settings. Integration of long read sequencing into hospital labs improves diagnostic workflows and enhances patient outcomes. Additionally, government funding and public-private partnerships support the adoption of advanced sequencing technologies in healthcare infrastructure.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing investments in genomics research, government support for precision medicine, and the rising prevalence of genetic disorders. Countries like China, Japan, and India are expanding their biotechnology infrastructure and research capabilities. Collaborations between local universities and global biotech firms are fuelling technological adoption. Moreover, the growing demand for personalized healthcare and increasing awareness about genomic testing contribute significantly to market expansion across the region.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the presence of major players, advanced healthcare infrastructure, and high R&D expenditure. The U.S., in particular, leads in the adoption of cutting-edge genomic technologies for clinical and research applications. The region benefits from established funding frameworks, robust regulatory systems, and widespread academic-industry collaborations. Unlike Asia Pacific, North America’s market maturity allows for rapid deployment of innovative sequencing platforms and large-scale population genomics initiatives.
Key players in the market
Some of the key players profiled in the Long Read Sequencing Market include Pacific Biosciences, Oxford Nanopore Technologies, Illumina Inc., BGI Genomics, MGI Tech, 10x Genomics, Agilent Technologies, Thermo Fisher Scientific, Qiagen, Bionano Genomics, Element Biosciences, Quantapore Inc., Universal Sequencing Technology, BaseClear BV, Cantata Bio, LLC, Future Genomics Technologies B.V., MicrobesNG and SeqLL, Inc.
Key Developments:
In May 2025, PacBio expanded its distribution agreement with Xi’an-based Haorui Gene, making Haorui the distributor for the Vega benchtop system across China and providing product support. Haorui had already deployed 10 Sequel II and Revio sequencers, focusing on blood typing genomics and HLA testing.
In October 2024, PacBio signed a research collaboration agreement to accelerate cancer genomics research in Asia, leveraging both its long-read (Revio) and short-read (Onso) sequencing platforms. The collaboration, supported by DKSH, aims to expand multi-omics research and precision oncology in the region.
In July 2024, Oxford Nanopore and Plasmidsaurus entered an expanded, multi-year strategic collaboration to transform the plasmid sequencing market using nanopore technology. This partnership aims to deliver rapid, high-quality, and cost-effective whole-plasmid sequencing, with plans to co-develop new technologies and applications for microbial and gene therapy use cases.
Products Covered:
• Instruments
• Consumables
• Services
Technologies Covered:
• Single-Molecule Real-Time (SMRT) Sequencing
• Nanopore Sequencing
• Synthetic Long-Read Sequencing
• Other Technologies
Applications Covered:
• Genomics
• Transcriptomics
• Epigenetics
• Metagenomics
• Other Applications
End Users Covered:
• Pharmaceutical & Biotechnology Companies
• Clinical Laboratories
• Hospitals & Healthcare Providers
• Contract Research Organizations (CROs)
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Long Read Sequencing Market, By Product
5.1 Introduction
5.2 Instruments
5.2.1 SMRT Sequencers
5.2.2 Nanopore Sequencers
5.3 Consumables
5.3.1 Reagents
5.3.2 Flow Cells
5.4 Services
5.4.1 Sequencing Services
5.4.2 Data Analysis Services
6 Global Long Read Sequencing Market, By Technology
6.1 Introduction
6.2 Single-Molecule Real-Time (SMRT) Sequencing
6.3 Nanopore Sequencing
6.4 Synthetic Long-Read Sequencing
6.5 Other Technologies
7 Global Long Read Sequencing Market, By Application
7.1 Introduction
7.2 Genomics
7.2.1 Whole Genome Sequencing (WGS)
7.2.2 De Novo Sequencing
7.2.3 Structural Variant Detection
7.3 Transcriptomics
7.3.1 Full-Length mRNA Sequencing
7.3.2 Isoform Identification
7.4 Epigenetics
7.4.1 DNA Methylation Analysis
7.4.2 Histone Modification Detection
7.5 Metagenomics
7.6 Other Applications
8 Global Long Read Sequencing Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Clinical Laboratories
8.4 Hospitals & Healthcare Providers
8.5 Contract Research Organizations (CROs)
8.6 Other End Users
9 Global Long Read Sequencing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Pacific Biosciences
11.2 Oxford Nanopore Technologies
11.3 Illumina Inc.
11.4 BGI Genomics
11.5 MGI Tech
11.6 10x Genomics
11.7 Agilent Technologies
11.8 Thermo Fisher Scientific
11.9 Qiagen
11.10 Bionano Genomics
11.11 Element Biosciences
11.12 Quantapore Inc.
11.13 Universal Sequencing Technology
11.14 BaseClear BV
11.15 Cantata Bio, LLC
11.16 Future Genomics Technologies B.V.
11.17 MicrobesNG
11.18 SeqLL, Inc.
List of Tables
1 Global Long Read Sequencing Market Outlook, By Region (2024-2032) ($MN)
2 Global Long Read Sequencing Market Outlook, By Product (2024-2032) ($MN)
3 Global Long Read Sequencing Market Outlook, By Instruments (2024-2032) ($MN)
4 Global Long Read Sequencing Market Outlook, By SMRT Sequencers (2024-2032) ($MN)
5 Global Long Read Sequencing Market Outlook, By Nanopore Sequencers (2024-2032) ($MN)
6 Global Long Read Sequencing Market Outlook, By Consumables (2024-2032) ($MN)
7 Global Long Read Sequencing Market Outlook, By Reagents (2024-2032) ($MN)
8 Global Long Read Sequencing Market Outlook, By Flow Cells (2024-2032) ($MN)
9 Global Long Read Sequencing Market Outlook, By Services (2024-2032) ($MN)
10 Global Long Read Sequencing Market Outlook, By Sequencing Services (2024-2032) ($MN)
11 Global Long Read Sequencing Market Outlook, By Data Analysis Services (2024-2032) ($MN)
12 Global Long Read Sequencing Market Outlook, By Technology (2024-2032) ($MN)
13 Global Long Read Sequencing Market Outlook, By Single-Molecule Real-Time (SMRT) Sequencing (2024-2032) ($MN)
14 Global Long Read Sequencing Market Outlook, By Nanopore Sequencing (2024-2032) ($MN)
15 Global Long Read Sequencing Market Outlook, By Synthetic Long-Read Sequencing (2024-2032) ($MN)
16 Global Long Read Sequencing Market Outlook, By Other Technologies (2024-2032) ($MN)
17 Global Long Read Sequencing Market Outlook, By Application (2024-2032) ($MN)
18 Global Long Read Sequencing Market Outlook, By Genomics (2024-2032) ($MN)
19 Global Long Read Sequencing Market Outlook, By Whole Genome Sequencing (WGS) (2024-2032) ($MN)
20 Global Long Read Sequencing Market Outlook, By De Novo Sequencing (2024-2032) ($MN)
21 Global Long Read Sequencing Market Outlook, By Structural Variant Detection (2024-2032) ($MN)
22 Global Long Read Sequencing Market Outlook, By Transcriptomics (2024-2032) ($MN)
23 Global Long Read Sequencing Market Outlook, By Full-Length mRNA Sequencing (2024-2032) ($MN)
24 Global Long Read Sequencing Market Outlook, By Isoform Identification (2024-2032) ($MN)
25 Global Long Read Sequencing Market Outlook, By Epigenetics (2024-2032) ($MN)
26 Global Long Read Sequencing Market Outlook, By DNA Methylation Analysis (2024-2032) ($MN)
27 Global Long Read Sequencing Market Outlook, By Histone Modification Detection (2024-2032) ($MN)
28 Global Long Read Sequencing Market Outlook, By Metagenomics (2024-2032) ($MN)
29 Global Long Read Sequencing Market Outlook, By Other Applications (2024-2032) ($MN)
30 Global Long Read Sequencing Market Outlook, By End User (2024-2032) ($MN)
31 Global Long Read Sequencing Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
32 Global Long Read Sequencing Market Outlook, By Clinical Laboratories (2024-2032) ($MN)
33 Global Long Read Sequencing Market Outlook, By Hospitals & Healthcare Providers (2024-2032) ($MN)
34 Global Long Read Sequencing Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
35 Global Long Read Sequencing Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
